Correlation Between Microbot Medical and KBC Group

Can any of the company-specific risk be diversified away by investing in both Microbot Medical and KBC Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microbot Medical and KBC Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Microbot Medical and KBC Group NV, you can compare the effects of market volatilities on Microbot Medical and KBC Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microbot Medical with a short position of KBC Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microbot Medical and KBC Group.

Diversification Opportunities for Microbot Medical and KBC Group

0.38

Correlation Coefficient

Microbot Medical  KBC Group

Weak diversification

The 3 months correlation between Microbot and KBC is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Microbot Medical and KBC Group NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on KBC Group NV and Microbot Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microbot Medical are associated (or correlated) with KBC Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of KBC Group NV has no effect on the direction of Microbot Medical i.e., Microbot Medical and KBC Group go up and down completely randomly.

Pair Corralation between Microbot Medical and KBC Group

Assuming the 90 days trading horizon Microbot Medical is expected to generate 2.82 times more return on investment than KBC Group. However, Microbot Medical is 2.82 times more volatile than KBC Group NV. It trades about 0.09 of its potential returns per unit of risk. KBC Group NV is currently generating about 0.19 per unit of risk. If you would invest  179.00  in Microbot Medical on April 21, 2025 and sell it today you would earn a total of  33.00  from holding Microbot Medical or generate 18.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Microbot Medical  vs.  KBC Group NV

Microbot Medical

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Microbot Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

KBC Group NV

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in KBC Group NV are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, KBC Group reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Microbot Medical and KBC Group

The main advantage of trading using opposite Microbot Medical and KBC Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microbot Medical position performs unexpectedly, KBC Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in KBC Group will offset losses from the drop in KBC Group's long position.

The idea behind Microbot Medical and KBC Group NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.